Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Model development of VEGF challenge in miniature swine

Meredith Weksler; Alan McDougal; Tyler Pegoraro; Stuart Williams; Mitchell A. deLong; Casey Kopczynski; David Hollander; Jeffrey C. White

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1312 – F0146. doi:

ARVO Annual Meeting Abstract June 2022

Ocular PK/PD of a Novel Non-Steroidal Anti-Inflammatory Compound in a Murine Model of Meibomian Gland Dysfunction

Alan McDougal; Robert Brown; Meredith Weksler; Steve Miller; Curtis Kelly; Maria Ina; Heeran Gordhan; Stuart Williams; David Ellis; Jeffrey C. White

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1989 – A0319. doi:

ARVO Annual Meeting Abstract June 2021

Novel corticosteroid class reduces inflammation and lowers IOP in animal models

Kevin Carbajal; Maria V. Zaretskaia; Cyndi L. Lichorowic; Jill M. Sturdivant; Meredith Weksler; Alan McDougal; Cheng-Wen Lin; Mitchell A. deLong; Casey Kopczynski; David A. Hollander; Jeff White

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1302. doi:

ARVO Annual Meeting Abstract June 2021

Ocular pharmacokinetics of a novel class of corticosteroids with ROCK inhibitory activity and potential for reduced steroid-associated risks

Maria V. Zaretskaia; Kevin Carbajal; Cyndi L. Lichorowic; Jill M. Sturdivant; Monica Germann; Christopher Romeo; Karen Crews; Angie Glendenning; Meredith Weksler; Alan McDougal; Mitchell A. deLong; Cheng-Wen Lin; Casey Kopczynski; David A. Hollander; Jeff White

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1292. doi:

ARVO Annual Meeting Abstract June 2020

A novel corticosteroid with ROCK inhibitory activity can reduce ocular inflammation and lower IOP in animal models

Kevin Carbajal; Maria V. Zaretskaia; Cyndi Lichorowic; Jill M. Sturdivant; Eric C Carlson; Monica Germann; Karen Crews; Meredith Weksler; Alan McDougal; Mitchell A. deLong; Casey Kopczynski; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2953. doi:

ARVO Annual Meeting Abstract June 2020

Novel corticosteroids with inhibitory activity against ROCK reach target ocular tissues and reduce inflammation in EIU

Maria V Zaretskaia; Kevin Carbajal; Cyndi Lichorowic; Jill M. Sturdivant; Eric C Carlson; Monica Germann; Karen Crews; Meredith Weksler; Alan McDougal; Mitchell A. deLong; Casey Kopczynski; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2983. doi:

ARVO Annual Meeting Abstract July 2019

Ocular Tissue Distribution and Duration of Release of AR-13503 Following Administration of AR-13503 Sustained Release Intravitreal Implant in Rabbits and Miniature Swine

Jindong Ding; Karen Crews; Kevin Carbajal; Meredith Weksler; Lori Moore; Eric C Carlson; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5387. doi:

ARVO Annual Meeting Abstract July 2019

Ocular Pharmacokinetics of a Novel Class of Selective Multi-Kinase Inhibitors with Anti-Inflammatory Potential

Kevin Carbajal; Karen Crews; Kyle Vick; Briana E Foley; Jindong Ding; Angie Glendenning; Meredith Weksler; Cynthia L Lichorowic; Jill Sturdivant; Mitchell A. deLong; Eric C Carlson; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):250. doi:

ARVO Annual Meeting Abstract July 2018

AR-13503 Enhances the Efficacy of Aflibercept in a Mouse Model of Proliferative Diabetic Retinopathy

Kevin Carbajal; Meredith Weksler; Lori Moore; Jindong Ding; Casey Kopczynski; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):200. doi:

ARVO Annual Meeting Abstract June 2017

Therapeutic Potential of Sustained Delivery of AR-13154(S) in an Animal Model of Proliferative Diabetic Retinopathy

Kevin Carbajal; Jindong Ding; Meredith Weksler; Lori Moore; Casey Kopczynski; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1977. doi:

Advertisement